Sarcomatous dermatofibrosarcoma protuberans metastasized to the lung: Preservation of CD34 expression in tumor cells

Pathology International

Volumn 48, Issue 12, 1998, Pages 989-993

  Ohtani, Noriko ^a,c   Fukusato, Toshio ^b   Tezuka, Fumiaki ^a  

^a SENDAI CITY MEDICAL CENTER   (Japan)

^b GUNMA UNIVERSITY HOSPITAL   (Japan)

^c TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

CD34; Dermatofibrosarcoma protuberans; Fibrosarcomatous change; Lung metastasis

Indexed keywords

CD34 ANTIGEN;

ADULT; ARTICLE; CANCER RECURRENCE; CASE REPORT; DERMATOFIBROSARCOMA PROTUBERANS; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG METASTASIS; LUNG RESECTION; PRIORITY JOURNAL; SPINDLE CELL SARCOMA;

EID: 0032407808     PISSN: 13205463     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1827.1998.tb03872.x     Document Type: Article

References (15)

1. McPeak CJ, Curz T, Nicastri AD. Dermatofibrosarcoma protuberans: An analysis of 86 cases-five with metastasis: Ann. Surg. 1967; 166: 803-815.
2. Ishii T, Koide O. An autopsy case of metastasizing protuberant dermatofibrosarcoma. Acta Pathol. Jpn. 1975; 25: 503-515.
3. Ding J, Hashimoto H, Enjoji M. Dermatofibrosarcoma protuberans with fibrosarcomatous areas: Clinicopathologic study of nine cases and comparison with allied tumors. Cancer 1989; 64: 721-729.
4. Connelly JH, Evans HL. Dermatofibrosarcoma protuberans: A Clinicopathologic review with emphasis on fibrosarcomatous areas. Am. J. Surg. Pathol. 1992; 16: 921-925.
5. Aiba S, Tabata N, Ishii H, Ohtani H, Tagami H. Dermatofibrosarcoma protuberans is a unique fibrohistiocytic tumor expressing CD34. Br. J. Dermatol. 1992; 127: 79-84.
6. Civin CI, Strauss LC, Brovall C et al. Antigenic analysis of hematopoiesis. III: A hematopoietic progenitor cell surface antigen defined by a monoclonal antibody raised against KG-1a cells. J. Immunol. 1984; 133: 157-165.
7. Enzinger FM, Weiss SW, eds. Soft Tissue Tumors, 3rd edn. Mosby, St Louis, 1995.
8. Weiss SW, Nickoloff BJ. CD-34 is expressed by a distinctive cell population in peripheral nerve, nerve sheath tumors, and related lesions. Am. J. Surg. Pathol. 1993; 17: 1039-1045.
9. Usigome S. CD34 expression in soft tissue tumors and its significance. Byori to Rinsyo 1995; 13: 79-85 (in Japanese with English abstract).
10. Goldblum JR. CD34 positivity in fibrosarcoma which arise in dermatofibrosarcoma protuberans. Arch. Pathol. Lab. Med. 1995; 119: 238-241.
11. Sato N, Kimura K, Tomita Y. Recurrent dermatofibrosarcoma protuberans with myxoid and fibrosarcomatous changes paralleled by loss of CD34 expression. J. Dermatol. 1995; 22: 665-672.
12. Von de Rijin M, Lombard CM, Rouse RV. Expression of CD34 by solitary fibrous tumors of the pleura, mediastinum, and lung. Am. J. Surg. Pathol. 1994; 18: 814-820.
13. Miettinen M, Virolainen M, Maarit-Sarlomo-Rikala. Gastrointestinal stromal tumors: Value of CD34 antigen in their identification and separation from true leiomyomas and schwannomas. Am. J. Surg. Pathol. 1995; 19: 207-216.
14. Meis JM. 'Dedifferentiation' in bone and soft-tissue tumors: A histological indicator of tumor progression. Pathol. Annu. 1991; 26: 37-62.
15. Calonje E, Fletcher CDM. Myoid diffferentiation in dermatofibrosarcoma protuberans and its fibrosarcomatous variant: Clinicopathologic analysis of 5 cases. J. Cutan. Pathol. 1996; 23: 30-36.